Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    LCZ 696

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck, Bayer's trial win for heart failure rival really boost Novartis' Entresto
    Merck, Bayer's trial win for heart failure rival really boost Novartis' Entresto

    20 Nov 2019

    // K. Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/pharma/merck-bayer-drug-s-trial-win-for-entresto-competitor-could-actually-be-a-boon-for-novartis

    K. Blankenship FIERCE PHARMA
    20 Nov 2019
    Share Share
    Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF
    Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF

    18 Nov 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/novartis-paragon-hf-analyses-suggest-entresto-benefit-beyond-hfref-300959592.html

    PR NEWSWIRE
    18 Nov 2019
    Share Share
    Merck, Bayer's trial win for heart failure rival really boost Novartis' Entresto
    Merck, Bayer's trial win for heart failure rival really boost Novartis' Entresto

    20 Oct 2019

    // K. Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/pharma/merck-bayer-drug-s-trial-win-for-entresto-competitor-could-actually-be-a-boon-for-novartis

    K. Blankenship FIERCE PHARMA
    20 Oct 2019
    Share Share
    Merck, Bayer's trial win for heart failure rival really boost Novartis' Entresto
    Merck, Bayer's trial win for heart failure rival really boost Novartis' Entresto

    20 Oct 2019

    // K. Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/pharma/merck-bayer-drug-s-trial-win-for-entresto-competitor-could-actually-be-a-boon-for-novartis

    K. Blankenship FIERCE PHARMA
    20 Oct 2019
    Share Share
    IDT Biologika opens vaccine manufacturing facility in Germany
    IDT Biologika opens vaccine manufacturing facility in Germany

    29 Jul 2019

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/idt-biologika-opens-vaccine-manufacturing-facility-germany

    Eric Palmer FIERCE PHARMA
    29 Jul 2019
    Share Share
    Blow for Entresto in latest heart failure trial
    Blow for Entresto in latest heart failure trial

    29 Jul 2019

    // Lucy Parsons PMLIVE

    http://www.pmlive.com/pharma_news/novartis_heart_failure_drug_entresto_fails_to_impress,_could_limit_growth_1295471

    Lucy Parsons PMLIVE
    29 Jul 2019
    Share Share